Pages that link to "Q45416054"
Jump to navigation
Jump to search
The following pages link to Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine (Q45416054):
Displaying 36 items.
- Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection (Q26775082) (← links)
- A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) (← links)
- Synthetic DNA vaccine strategies against persistent viral infections (Q27016078) (← links)
- Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine (Q28742137) (← links)
- GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates (Q28751705) (← links)
- Preclinical studies of human immunodeficiency virus/AIDS vaccines: inverse correlation between avidity of anti-Env antibodies and peak postchallenge viremia. (Q30374995) (← links)
- Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV. (Q33575384) (← links)
- Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs (Q33652911) (← links)
- Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virus (Q33769283) (← links)
- DNA/MVA Vaccines for HIV/AIDS (Q34492802) (← links)
- A chimeric HIV-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (GM-CSF) domain induces enhanced antibody and T cell responses (Q35063075) (← links)
- Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination (Q35208657) (← links)
- Clinical applications of DNA vaccines: current progress (Q35452312) (← links)
- Technologies for enhanced efficacy of DNA vaccines (Q35802958) (← links)
- Incorporation of a GPI-anchored engineered cytokine as a molecular adjuvant enhances the immunogenicity of HIV VLPs (Q35824686) (← links)
- HIV DNA Vaccine: Stepwise Improvements Make a Difference (Q35826742) (← links)
- Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine (Q36141586) (← links)
- Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid (Q36276936) (← links)
- GM-CSF DNA: an adjuvant for higher avidity IgG, rectal IgA, and increased protection against the acute phase of a SHIV-89.6P challenge by a DNA/MVA immunodeficiency virus vaccine (Q36407775) (← links)
- Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses (Q36424574) (← links)
- Co-administration of plasmid-encoded granulocyte-macrophage colony-stimulating factor increases human immunodeficiency virus-1 DNA vaccine-induced polyfunctional CD4+ T-cell responses. (Q36450329) (← links)
- An HIV-1 Mini Vaccine Induced Long-lived Cellular and Humoral Immune Responses (Q36625724) (← links)
- Improving vaccines by incorporating immunological coadjuvants (Q36899084) (← links)
- Encoded novel forms of HSP70 or a cytolytic protein increase DNA vaccine potency (Q37154783) (← links)
- Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial (Q37216571) (← links)
- Dynamics of cytokine/chemokine responses in intestinal CD4+ and CD8+ T Cells during Acute Simian Immunodeficiency Virus Infection (Q37252772) (← links)
- Modulation of HIV-1 immunity by adjuvants (Q37698564) (← links)
- Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines. (Q37873932) (← links)
- Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits (Q38356290) (← links)
- Immune responses of two recombinant adenoviruses expressing VP1 antigens of FMDV fused with porcine granulocyte macrophage colony-stimulating factor (Q40057372) (← links)
- Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models (Q40071705) (← links)
- High Doses of GM-CSF Inhibit Antibody Responses in Rectal Secretions and Diminish Modified Vaccinia Ankara/Simian Immunodeficiency Virus Vaccine Protection in TRIM5α-Restrictive Macaques. (Q40523370) (← links)
- Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR. (Q41995734) (← links)
- Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques (Q45187443) (← links)
- Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins (Q47276928) (← links)
- Effects of immunization against a DNA vaccine encoding somatostatin gene (pGM-CSF/SS) by attenuated Salmonella typhimurium on growth, reproduction and lactation in female mice (Q50046028) (← links)